Pharmaceutical Technology5d
Cirtuvivint by Biosplice Therapeutics for Refractory Acute Myeloid Leukemia: Likelihood of Approval
Cirtuvivint is under clinical development by Biosplice Therapeutics and currently in Phase I for Refractory Acute Myeloid Leukemia.
ZetrOZ System's sam(R) Ultrasound Treatment Helps Top Triathlete Return to the Boston Marathon
Former triathlon champ Claudia McCoy used the breakthrough wearable ultrasound unit to boost her recovery from injuries so ...
ZetrOZ Systems Educate Healthcare and Workers Compensation Professionals on How sam Treatment Improves Healing and Reduces Costs
'At ZetrOZ Systems, we are dedicated to not only developing revolutionary medical technology but also to helping the ...
Pharmaceutical Technology5d
Cirtuvivint by Biosplice Therapeutics for Myelodysplastic Syndrome: Likelihood of Approval
Cirtuvivint is under clinical development by Biosplice Therapeutics and currently in Phase I for Myelodysplastic Syndrome.
rmdopen.bmj4d
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study
Objectives To assess the effect of treatment on haemostatic parameters in patients with early rheumatoid arthritis (RA).
Impacts4d
The Integration of Regenerative Medicine and Technology in Pain Management
Pain management has seen a profound transformation in recent years, driven by advancements in regenerative medicine and ...
Medscape2d
Turmeric Supplements Show Promise in Treating Arthritis
This version was used in subsequent experiments and was shown to prevent acute and chronic arthritis, even when it was administered after arthritis had been induced. In addition, turmeric ...
Too Old to Operate6d
Validation of a Patient Reported Definition for Acute CPP Crystal Arthritis
The following is a summary of “Development and internal-external cross-validation of a patient-reported definition for acute calcium pyrophosphate crystal arthritis,” published in the December 2024 ...